KRONOX LAB SCIENCES LIMITED

Board approved audited standalone results for Q4 and FY26 ended March 31, 2026, with an unmodified audit opinion. Recommended a final dividend of 5% (₹0.50 per share) for FY26, subject to shareholder

Kronox Lab Sciences reported audited standalone FY26 net profit of ₹276.60 crore on total income of ₹1,064.14 crore. The board declared a final dividend of 5% (₹0.50 per share of ₹10 each) for the fin

Board approved audited standalone financial results for Q4 and FY ended March 31, 2026, reporting a 36% YoY rise in net profit to ₹27.67 crore. Recommended a final dividend of 5% (₹0.50 per share) for